vs

Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $111.5M, roughly 1.7× AVIAT NETWORKS, INC.). AVIAT NETWORKS, INC. runs the higher net margin — 5.1% vs -57.9%, a 63.0% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs -5.7%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 0.3%).

Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

AVNW vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.7× larger
NEO
$186.7M
$111.5M
AVNW
Growing faster (revenue YoY)
NEO
NEO
+16.8% gap
NEO
11.1%
-5.7%
AVNW
Higher net margin
AVNW
AVNW
63.0% more per $
AVNW
5.1%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
0.3%
AVNW

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
AVNW
AVNW
NEO
NEO
Revenue
$111.5M
$186.7M
Net Profit
$5.7M
$-108.0M
Gross Margin
32.4%
43.3%
Operating Margin
6.5%
46.9%
Net Margin
5.1%
-57.9%
Revenue YoY
-5.7%
11.1%
Net Profit YoY
27.2%
42.0%
EPS (diluted)
$0.44
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNW
AVNW
NEO
NEO
Q1 26
$186.7M
Q4 25
$111.5M
$190.2M
Q3 25
$107.3M
$187.8M
Q2 25
$115.3M
$181.3M
Q1 25
$112.6M
$168.0M
Q4 24
$118.2M
$172.0M
Q3 24
$88.4M
$167.8M
Q2 24
$116.7M
$164.5M
Net Profit
AVNW
AVNW
NEO
NEO
Q1 26
$-108.0M
Q4 25
$5.7M
Q3 25
$162.0K
$-27.1M
Q2 25
$5.2M
$-45.1M
Q1 25
$3.5M
$-25.9M
Q4 24
$4.5M
Q3 24
$-11.9M
$-17.7M
Q2 24
$1.5M
$-18.6M
Gross Margin
AVNW
AVNW
NEO
NEO
Q1 26
43.3%
Q4 25
32.4%
43.8%
Q3 25
33.2%
42.8%
Q2 25
34.2%
42.6%
Q1 25
34.9%
43.6%
Q4 24
34.6%
44.9%
Q3 24
22.4%
44.6%
Q2 24
35.3%
44.1%
Operating Margin
AVNW
AVNW
NEO
NEO
Q1 26
46.9%
Q4 25
6.5%
-7.1%
Q3 25
4.8%
-14.4%
Q2 25
7.7%
-26.3%
Q1 25
8.3%
-16.6%
Q4 24
6.7%
-10.7%
Q3 24
-17.6%
-12.6%
Q2 24
4.7%
-13.3%
Net Margin
AVNW
AVNW
NEO
NEO
Q1 26
-57.9%
Q4 25
5.1%
Q3 25
0.2%
-14.4%
Q2 25
4.5%
-24.9%
Q1 25
3.1%
-15.4%
Q4 24
3.8%
Q3 24
-13.4%
-10.5%
Q2 24
1.3%
-11.3%
EPS (diluted)
AVNW
AVNW
NEO
NEO
Q1 26
$-0.13
Q4 25
$0.44
Q3 25
$0.01
Q2 25
$0.42
Q1 25
$0.27
Q4 24
$0.35
Q3 24
$-0.94
Q2 24
$0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNW
AVNW
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$86.5M
$146.1M
Total DebtLower is stronger
$105.4M
Stockholders' EquityBook value
$271.6M
$828.8M
Total Assets
$659.4M
$1.3B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNW
AVNW
NEO
NEO
Q1 26
$146.1M
Q4 25
$86.5M
$159.6M
Q3 25
$64.8M
$164.1M
Q2 25
$59.7M
$154.7M
Q1 25
$49.4M
$346.2M
Q4 24
$52.6M
$367.0M
Q3 24
$51.0M
$362.0M
Q2 24
$64.6M
$355.1M
Total Debt
AVNW
AVNW
NEO
NEO
Q1 26
Q4 25
$105.4M
$341.9M
Q3 25
$106.5M
Q2 25
$87.6M
Q1 25
$73.9M
Q4 24
$74.9M
$541.1M
Q3 24
$83.4M
Q2 24
$48.4M
Stockholders' Equity
AVNW
AVNW
NEO
NEO
Q1 26
$828.8M
Q4 25
$271.6M
$836.6M
Q3 25
$263.6M
$838.3M
Q2 25
$263.2M
$854.0M
Q1 25
$256.1M
$888.3M
Q4 24
$249.6M
$902.3M
Q3 24
$247.1M
$908.2M
Q2 24
$255.9M
$915.9M
Total Assets
AVNW
AVNW
NEO
NEO
Q1 26
$1.3B
Q4 25
$659.4M
$1.4B
Q3 25
$643.3M
$1.4B
Q2 25
$633.3M
$1.4B
Q1 25
$628.3M
$1.6B
Q4 24
$594.1M
$1.6B
Q3 24
$590.9M
$1.6B
Q2 24
$535.2M
$1.6B
Debt / Equity
AVNW
AVNW
NEO
NEO
Q1 26
Q4 25
0.39×
0.41×
Q3 25
0.40×
Q2 25
0.33×
Q1 25
0.29×
Q4 24
0.30×
0.60×
Q3 24
0.34×
Q2 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNW
AVNW
NEO
NEO
Operating Cash FlowLast quarter
$23.9M
$-8.1M
Free Cash FlowOCF − Capex
$22.5M
FCF MarginFCF / Revenue
20.2%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
4.18×
TTM Free Cash FlowTrailing 4 quarters
$16.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNW
AVNW
NEO
NEO
Q1 26
$-8.1M
Q4 25
$23.9M
$1.3M
Q3 25
$-11.7M
$8.9M
Q2 25
$10.5M
$20.3M
Q1 25
$1.6M
$-25.3M
Q4 24
$20.8M
$9.8M
Q3 24
$-27.2M
$9.2M
Q2 24
$8.3M
$13.9M
Free Cash Flow
AVNW
AVNW
NEO
NEO
Q1 26
Q4 25
$22.5M
$-6.5M
Q3 25
$-13.5M
$570.0K
Q2 25
$8.2M
$14.0M
Q1 25
$-1.2M
$-29.8M
Q4 24
$18.3M
$-1.8M
Q3 24
$-32.6M
$-1.6M
Q2 24
$7.5M
$814.0K
FCF Margin
AVNW
AVNW
NEO
NEO
Q1 26
Q4 25
20.2%
-3.4%
Q3 25
-12.6%
0.3%
Q2 25
7.1%
7.7%
Q1 25
-1.0%
-17.8%
Q4 24
15.5%
-1.0%
Q3 24
-36.8%
-0.9%
Q2 24
6.4%
0.5%
Capex Intensity
AVNW
AVNW
NEO
NEO
Q1 26
Q4 25
1.3%
4.1%
Q3 25
1.6%
4.4%
Q2 25
2.0%
3.5%
Q1 25
2.5%
2.7%
Q4 24
2.1%
6.7%
Q3 24
6.1%
6.4%
Q2 24
0.7%
8.0%
Cash Conversion
AVNW
AVNW
NEO
NEO
Q1 26
Q4 25
4.18×
Q3 25
-72.48×
Q2 25
2.02×
Q1 25
0.46×
Q4 24
4.62×
Q3 24
Q2 24
5.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNW
AVNW

Products$81.2M73%
Services$30.3M27%

NEO
NEO

Segment breakdown not available.

Related Comparisons